OTCMKTS:GBCS Selectis Health (GBCS) Stock Price, News & Analysis $2.21 -0.04 (-1.84%) As of 02:51 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About Selectis Health Stock (OTCMKTS:GBCS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Selectis Health alerts:Sign Up Key Stats Today's Range$2.20▼$2.2150-Day Range$2.00▼$2.5052-Week Range$0.41▼$4.50Volume2,200 shsAverage Volume6,223 shsMarket Capitalization$6.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care. Read More Selectis Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreGBCS MarketRank™: Selectis Health scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Selectis Health. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Selectis Health is -2.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Selectis Health is -2.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Selectis Health's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.01% of the outstanding shares of Selectis Health have been sold short.Short Interest Ratio / Days to CoverSelectis Health has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Selectis Health has recently increased by 50.00%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSelectis Health does not currently pay a dividend.Dividend GrowthSelectis Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.01% of the outstanding shares of Selectis Health have been sold short.Short Interest Ratio / Days to CoverSelectis Health has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Selectis Health has recently increased by 50.00%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News SentimentSelectis Health has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Selectis Health this week, compared to 0 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Selectis Health insiders have not sold or bought any company stock.Percentage Held by Insiders15.20% of the stock of Selectis Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Selectis Health's insider trading history. Receive GBCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Selectis Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GBCS Stock News HeadlinesSelectis Health Delays Q1 2025 10-Q FilingMay 15, 2025 | tipranks.comSelectis Health Delays Yearly Report FilingMarch 31, 2025 | tipranks.comU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - which altcoins are positioned for massive gains and how to build the perfect portfolio.October 2 at 2:00 AM | Crypto 101 Media (Ad)Selectis Health Makes Key Leadership AnnouncementOctober 17, 2024 | globenewswire.comGBCS Stock Earnings: Selectis Health Reported Results for Q1 2024August 16, 2024 | investorplace.comSelectis Health Completes Sale of Archway Transitional Care Center in GeorgiaJune 21, 2024 | globenewswire.comSelectis Health Enters Definitive Purchase and Sale Agreement for Archway Transitional Care Center in GeorgiaMay 9, 2024 | globenewswire.comBest Electric Wheelchairs Of 2024April 24, 2024 | forbes.comSee More Headlines GBCS Stock Analysis - Frequently Asked Questions How have GBCS shares performed this year? Selectis Health's stock was trading at $1.12 at the beginning of 2025. Since then, GBCS stock has increased by 97.2% and is now trading at $2.2085. How were Selectis Health's earnings last quarter? Selectis Health, Inc. (OTCMKTS:GBCS) released its earnings results on Thursday, August, 14th. The company reported ($0.10) earnings per share for the quarter. The firm earned $10.44 million during the quarter. When did Selectis Health's stock split? Shares of Selectis Health reverse split before market open on Wednesday, September 22nd 2021.The 1-10 reverse split was announced on Wednesday, September 22nd 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 22nd 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Selectis Health? Shares of GBCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Selectis Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Selectis Health investors own include Chemed (CHE), Walt Disney (DIS), OceanFirst Financial (OCFC), Celanese (CE), Credit Acceptance (CACC), Blackstone Mortgage Trust (BXMT) and Blackstone (BX). Company Calendar Last Earnings8/14/2025Today10/02/2025Next Earnings (Estimated)11/10/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Services Sub-IndustryTrading Current SymbolOTCMKTS:GBCS CIK727346 Webwww.gbcsreit.com Phone(720) 680-0808Fax303-527-2916Employees500Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.42 million Net Margins-7.61% Pretax Margin-7.61% Return on EquityN/A Return on Assets-9.29% Debt Debt-to-Equity RatioN/A Current Ratio0.19 Quick Ratio0.19 Sales & Book Value Annual Sales$39.49 million Price / Sales0.17 Cash FlowN/A Price / Cash FlowN/A Book Value($2.02) per share Price / Book-1.09Miscellaneous Outstanding Shares3,070,000Free Float2,601,000Market Cap$6.78 million OptionableNot Optionable Beta-0.34 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (OTCMKTS:GBCS) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTrump’s Fast-Track Plan: These 3 Stocks Are Set to SoarAI isn't the only game-changer on Wall Street right now. Behind the scenes, President Trump is fast-trackin...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Biotech has a clinical approach that intrigues investorsThis biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. ...i2i Marketing Group, LLC | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Selectis Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Selectis Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
